121 related articles for article (PubMed ID: 4299216)
1. Mechanism of diazoxide hyperglycemia in animals.
Tabachnick II; Gulbenkian A
Ann N Y Acad Sci; 1968 Apr; 150(2):204-18. PubMed ID: 4299216
[No Abstract] [Full Text] [Related]
2. Biochemical aspects of the hyperglycemic action of diazoxide.
Senft G
Ann N Y Acad Sci; 1968 Apr; 150(2):242-55. PubMed ID: 4299217
[No Abstract] [Full Text] [Related]
3. Mode of action of a diazoxide analog (A025). Its effects on insulin secretion.
Grant AM; Basabe JC; Lopez NL; Krees SV; Wolff FW
Diabetes; 1970 Sep; 19(9):630-8. PubMed ID: 4990295
[No Abstract] [Full Text] [Related]
4. The action of diazoxide on insulin secretion, medullo-adrenal secretion, and the liberation of catecholamines.
Loubatières A; Mariani MM; Alric R
Ann N Y Acad Sci; 1968 Apr; 150(2):226-41. PubMed ID: 4875709
[No Abstract] [Full Text] [Related]
5. Inhibition of insulin release by diazoxide and its relation to catecholamine effects in man.
Porte D
Ann N Y Acad Sci; 1968 Apr; 150(2):281-91. PubMed ID: 4299220
[No Abstract] [Full Text] [Related]
6. AO44: an improved hyperglycemic agent.
Lopez N; Basabe J; Grant A; Krees S; Terry M; Viktora J; Wolff F
Metabolism; 1971 Apr; 20(4):373-83. PubMed ID: 5550304
[No Abstract] [Full Text] [Related]
7. Insulin secretory blockade by benzothiadiazines and catecholamines: reversal by sulfonylureas.
Seltzer HS; Crout JR
Ann N Y Acad Sci; 1968 Apr; 150(2):309-21. PubMed ID: 4875710
[No Abstract] [Full Text] [Related]
8. [Pharmacological studies of a new highly effective blood sugar decreasing sulfonamide, glibenclamide (HB 419)].
Loubatières A; Mariani MM; Ribes G; de Malbosc H; Alric R; Chapal J
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1354-63. PubMed ID: 4899083
[No Abstract] [Full Text] [Related]
9. On the mechanism of diazoxide-induced hyperglycemia.
Altszuler N; Moraru E; Hampshire J
Diabetes; 1977 Oct; 26(10):931-5. PubMed ID: 908462
[TBL] [Abstract][Full Text] [Related]
10. Hyperglycemia and inhibition of insulin secretion during administration of diazoxide and trichlormethiazide in man.
Seltzer HS; Allen EW
Diabetes; 1969 Jan; 18(1):19-28. PubMed ID: 5761863
[No Abstract] [Full Text] [Related]
11. Further studies on diazoxide suppression of insulin release from abnormal and normal islet tissue in man.
Fajans SS; Floyd JC; Thiffault CA; Knopf RF; Harrison TS; Conn JW
Ann N Y Acad Sci; 1968 Apr; 150(2):261-80. PubMed ID: 4299219
[No Abstract] [Full Text] [Related]
12. Hyperresponsiveness to tolbutamide of dogs pretreated with diazoxide.
Anderson JH; Byrd GW; Blackard WG
Metabolism; 1971 Nov; 20(11):1023-30. PubMed ID: 4329940
[No Abstract] [Full Text] [Related]
13. [Study of a mechanism of hyperglycemic action of nicotinamide].
Macabies J; Sassine A; Bourgeois JM
C R Seances Soc Biol Fil; 1970; 164(7):1570-2. PubMed ID: 4251946
[No Abstract] [Full Text] [Related]
14. [Hyperglycemic effect and glycogenolytic action of catecholamines].
Moratinos J; Ellis S
Arch Farmacol Toxicol; 1978 Aug; 4(2):189-210. PubMed ID: 31843
[No Abstract] [Full Text] [Related]
15. Diazoxide-induced long-term hyperglycemia. I. Preservation of B-cell insulin-releasing capacity.
Gomis R; Plaza C; Malaisse WJ
Diabetes Res; 1988 Dec; 9(4):183-6. PubMed ID: 3073904
[TBL] [Abstract][Full Text] [Related]
16. AN ADRENERGIC MECHANISM FOR HYPERGLYCEMIA INDUCED BY DIAZOXIDE.
STAQUET M; YABO R; VIKTORA J; WOLFF F
Metabolism; 1965 Sep; 14():1000-9. PubMed ID: 14327264
[No Abstract] [Full Text] [Related]
17. [Participation of insulin in diazoxide hyperglycemia].
Losert W; Senft G; Sitt R; Schultz G; Kaess H
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1966; 253(3):388-94. PubMed ID: 4223206
[No Abstract] [Full Text] [Related]
18. [Persistance of insulin secretion in hyperglycemia induced with urethane].
Bourgeois JM; Sassine A; Macabies J
C R Seances Soc Biol Fil; 1970; 164(11):2341-5. PubMed ID: 4257368
[No Abstract] [Full Text] [Related]
19. Effect of diazoxide on golden hamsters with chronic hypoglycemia due to a transplantable islet-cell tumor.
Lefebvre P; Luyckx A; Cession-Fossion A
Horm Metab Res; 1972 Sep; 4(5):355-60. PubMed ID: 4345752
[No Abstract] [Full Text] [Related]
20. The morphological substrate of the inhibition of insulin secretion by diazoxide.
Creutzfeldt W; Creutzfeldt C; Frerichs H; Perings E; Sicklinger K
Horm Metab Res; 1969 Mar; 1(2):53-64. PubMed ID: 4334867
[No Abstract] [Full Text] [Related]
[Next] [New Search]
